L!NCS Launches Pathfinder Lab, Ushering in a New Era of Precision Cancer Care in the Philippines

L!NCS – Linking Network for Cancer Services Inc. – marked a groundbreaking milestone in Philippine healthcare with the inauguration of its state-of-the-art genomics laboratory, Pathfinder Lab. Located at Unit 7D, Strata 100 Building, Emerald Avenue, Ortigas Central Business District, Pasig City, Pathfinder Lab will provide Filipinos with access to advanced genomic testing, revolutionizing cancer care and bringing personalized treatment to the forefront.

“This is more than just the opening of a laboratory; it’s the opening of a new chapter in Philippine healthcare,” said Dr Necy Juat of L!NCS. “Pathfinder Lab represents our unwavering commitment to providing equitable, world-class cancer care for every Filipino patient.  We are proud to bring this groundbreaking technology home, making precision medicine accessible and empowering doctors to deliver more targeted and effective treatments.”

Dr. Catherine Teh                       Dr. Necy Juat, MD            Dr. Christina Galvez, MD

Chair of the Board                      Operations Director                     HR Director

   Dr. Annielyn Beryl Ong-Cornel, MD         Dr. Jhade Lotus Peneyra

   Marketing Director                      Finance Director

Pathfinder Lab utilizes Next-Generation Sequencing (NGS) technology, which maps the genetic code of a tumor, allowing doctors to:

-          Choose medications that directly target the specific cancer.

 -          Preclude the administration of medications which might be ineffectual to the

cancer being treated.

 -          Minimize side effects.

 -          Act faster and with greater confidence.

his personalized approach to cancer care empowers patients and their families with knowledge and hope, offering a stronger chance of recovery and a more positive experience throughout their journey.

The launch of Pathfinder Lab is a testament to L!NCS’ dedication to innovation and its commitment to improving the lives of Filipinos battling cancer.  This milestone is also a significant step towards achieving the goals of the National Integrated Cancer Control Act, aiming to improve access to high-quality cancer care across the country.

To learn more about genomic testing and its potential to transform cancer care www.lincsconsulting.com